Syndecan-1 in B lymphoid malignancies

被引:59
|
作者
Sanderson, RD
Borset, M
机构
[1] Univ Arkansas Med Sci, Arkansas Canc Res Ctr, Dept Pathol, Little Rock, AR 72205 USA
[2] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7034 Trondheim, Norway
关键词
syndecan; myeloma; heparan sulfate; hepatocyte growth factor; cancer;
D O I
10.1007/s00277-002-0437-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Syndecans are heparan sulfate-bearing proteoglycans that are found on the surface of most cells. Syndecan-1 is expressed predominantly on epithelia, but is also present on pre-B cells and plasma cells. The syndecans act to bind various effector molecules via their heparan sulfate chains, including both soluble and insoluble molecules within the extracellular milieu. These interactions promote cell adhesion to extracellular matrix and to adjacent cells. In addition, the syndecans can bind to and affect the biological activity of a number of heparin-binding growth factors. Thus, syndecan-1 can play a dramatic role in regulating cell behavior. In this review we discuss the expression of syndecan-1 on malignant B lymphoid cells as well as specific structure-function relationships of the molecule. Emphasis is placed on the important role that syndecan-1 has in regulating the growth of B lymphoid malignancies, particularly multiple myeloma.
引用
收藏
页码:125 / 135
页数:11
相关论文
共 50 条
  • [1] Syndecan-1 in B lymphoid malignancies
    R. Sanderson
    M. Børset
    Annals of Hematology, 2002, 81 : 125 - 135
  • [2] The role of syndecan-1 in malignancies
    Inki, P
    Jalkanen, M
    ANNALS OF MEDICINE, 1996, 28 (01) : 63 - 67
  • [3] Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment
    Dhodapkar, MV
    Sanderson, RD
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 35 - 43
  • [4] Diagnostic and Prognostic Value of Soluble Syndecan-1 in Pleural Malignancies
    Mundt, Filip
    Heidari-Hamedani, Ghazal
    Nilsonne, Gustav
    Metintas, Muzaffer
    Hjerpe, Anders
    Dobra, Katalin
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] INTERLEUKIN-6 REGULATES EXPRESSION OF THE SYNDECAN-1 PROTEOGLYCAN ON B-LYMPHOID-CELLS
    SNEED, TB
    STANLEY, DJ
    YOUNG, LA
    SANDERSON, RD
    CELLULAR IMMUNOLOGY, 1994, 153 (02) : 456 - 467
  • [6] Syndecan-1 in Liver Diseases
    Regos, Eszter
    Karaszi, Katalin
    Reszegi, Andrea
    Kiss, Andras
    Schaff, Zsuzsa
    Baghy, Kornelia
    Kovalszky, Ilona
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 813 - 819
  • [7] Focus on Molecules: Syndecan-1
    Zhang, Yinghui
    McKown, Robert L.
    Raab, Ronald W.
    Rapraeger, Alan C.
    Laurie, Gordon W.
    EXPERIMENTAL EYE RESEARCH, 2011, 93 (04) : 329 - 330
  • [8] Syndecan-1 is Protective in Atherosclerosis
    Haller, Carolyn A.
    Smith, Sumona
    Wen, Jing
    Xiao, Jiantao
    Chaikof, Elliot L.
    CIRCULATION, 2009, 120 (18) : S1066 - S1066
  • [9] Syndecan-1 in the Tumor Microenvironment
    Handra-Luca, Adriana
    TUMOR MICROENVIRONMENT: EXTRACELLULAR MATRIX COMPONENTS - PT B, 2020, 1272 : 39 - 53
  • [10] Syndecan-1 in Endometrial Cancers
    Kim, J.
    Choi, D.
    Kim, J.
    Min, C.
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17